Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS

CONTEXT: Antiresorptive therapy significantly reduces fracture risk in patients with benign bone disease and skeletal-related events (SREs) in patients with bone metastases (BM). Osteonecrosis of the jaw (ONJ) is a rare but severe condition manifested as necrotic bone lesion or lesions of the jaws....

Descripción completa

Detalles Bibliográficos
Autores principales: Anastasilakis, Athanasios D, Pepe, Jessica, Napoli, Nicola, Palermo, Andrea, Magopoulos, Christos, Khan, Aliya A, Zillikens, M Carola, Body, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Reports and Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016445/
https://www.ncbi.nlm.nih.gov/pubmed/34922381
http://dx.doi.org/10.1210/clinem/dgab888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016445/
https://www.ncbi.nlm.nih.gov/pubmed/34922381
http://dx.doi.org/10.1210/clinem/dgab888

Ejemplares similares